LearnGlossaryMarketStocksSuperinvestorsSign in

CGC

Canopy Growth Corporation

Healthcare · $397M market cap

Verdict

We can't put a fair value on CGC right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth12.5% a year✓
Sales growth9.2% a year✗
Free cash flow growth—?
Return on invested capital-13.5%✗

Follow CGC

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Canopy Growth Corporation

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global…

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works